EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets

Qianying Ouyang, Qianyu Hu, Caiqin Wang, Yizi He, Ruolan Zeng, Yajun Li, Chang Su, Guige Lu, Xueting Zhu, Ling Xiao, Hui Zhou

MedComm · 2026-03 · 7 (3)

DOI: 10.1002/mco2.70675 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 10.03.2026. Verfasst von Qianying Ouyang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma & Hematology The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital Chang…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Warburg effect states that cancer cells preferentially undergo aerobic glycolysis, producing lactate as a key metabolic byproduct. Lactate acidifies the tumor microenvironment (TME) and serves as a signaling molecule and substrate for lysine lactylation (Kla), a novel posttranslational modification (PTM) discovered in 2019 that links glycolytic metabolism to epigenetic and proteomic reprogramming. The reversible modification of histones and nonhistone proteins orchestrates oncogenic adaptation and drives tumor progression. However, gaps persist in our understanding of the multifactorial regulation of lactylation and its translational potential in overcoming tumor heterogeneity and resistance. This review highlights the emerging roles of lactylation in cancer therapies, including the enhancement of DNA repair mechanisms during chemotherapy, stabilization of key signaling effectors upon targeted therapy, and promotion of an immunosuppressive TME in immunotherapy. We further examined regulatory factors associated with lactylation, from competitive PTMs and genetic mutations to microbial influences and environmental signals. Additionally, we discuss the therapeutic potential of targeting lactylation via indirect modulators currently under investigation and the visualization of lactate and lactylation modifications. By synthesizing these insights, this review highlights lactylation as a reversible metabolic‐epigenetic axis for precision oncology, enabling predictive biomarkers, combination strategies, and novel interventions to address the dynamic challenges of cancer.

Schlagwörter

Stichwörter der Autor:innen

lactatelactylationmetabolic‐epigenetic axisprecision oncology

Autor:innen und Institutionen

  • Department of Lymphoma & Hematology The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital Changsha China.
  • Department of Histology and Embryology Xiangya School of Basic Medical Sciences Central South University Changsha China.
  • Graduate Collaborative Training Base of Hunan Cancer Hospital University of South China Hengyang China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ouyang, Q., Hu, Q., Wang, C., He, Y., Zeng, R., Li, Y., Su, C., Lu, G., Zhu, X., Xiao, L., & Zhou, H. (2026). Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets. MedComm, 7(3). https://doi.org/10.1002/mco2.70675

Vancouver

Ouyang Q, Hu Q, Wang C, He Y, Zeng R, Li Y, et al. Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets. MedComm. 2026;7(3). doi:10.1002/mco2.70675

BibTeX
@article{Ouyang2026,
  author = {Ouyang, Qianying and Hu, Qianyu and Wang, Caiqin and He, Yizi and Zeng, Ruolan and Li, Yajun and Su, Chang and Lu, Guige and Zhu, Xueting and Xiao, Ling and Zhou, Hui},
  title = {Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1002/mco2.70675}
}
Kostenlos starten →